Stay updated on NasoVAX Extension Safety and Immunogenicity Clinical Trial
Sign up to get notified when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.

Latest updates to the NasoVAX Extension Safety and Immunogenicity Clinical Trial page
- CheckyesterdayChange DetectedVisual redesign of the study details page is evident, while the underlying study data (eligibility criteria, primary and secondary outcomes, and study status) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check8 days agoNo Change Detected
- Check30 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference6%

- Check37 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated to v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed.SummaryDifference0.4%

- Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.4%

- Check65 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms and the previous revision number have been removed.SummaryDifference4%

Stay in the know with updates to NasoVAX Extension Safety and Immunogenicity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.